Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Hematologic Oncology Update · Feb 18, 2026 · 57:58
Hematologic Oncology Update · Feb 18, 2026 · 57:58
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.
Episodes: Hematologic Oncology Update
